C4 Therapeutics Corp (CCCC) - Rasio kapitalisasi marang bathi resik

C4 Therapeutics, Inc. (CCCC) is developing a protein degradation system to combat neoplasms, leveraging cutting-edge science and alliances with industry behemoths. However, high research costs and uncertainty surrounding primary tests create certain risks. This market valuation chart reflects a value of -3.90, while current quotes already price in development complexities, and capital inflows from global partners provide a tangible impulse.

CCCC c4therapeutics.com: Koefisien rega marang bathi ing interval 04.07.2022 - 15.11.2026

Rincian metrik komprehensif lan analitis C4 Therapeutics Corp (CCCC)

- rega pasar lan target rega analis:

Rega bursa C4 Therapeutics|CCCC - Prakiraan konsensus analis

- indikator kapitalisasi pasar:

Kapitalisasi pasar C4 Therapeutics Corp|CCCC - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- data nilai buku modal saham:

Nilai Aset Bersih saben Saham C4 Therapeutics|CCCC - Aset Bersih Perusahaan|Nilai Pasar marang Nilai Buku c4therapeutics.com|CCCC - Gunggung Aset Perusahaan

- statistik kawajiban utang lan likuiditas:

- data bathi bisnis lan rasio investasi:

CCCC - Penghasilan resik|Bathi resik mangsa ngarep C4 Therapeutics, Inc.|CCCC - Pangali P/E|Rasio prakiraan rega marang bathi C4 Tx|CCCC - Pangali PEG|Nilai perusahaan marang bathi operasional sadurunge panyusutan C4 Therapeutics Corp|CCCC - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajroning taun lumaku C4 Therapeutics|CCCC - Bathi resik saben saham sajrone 12 wulan pungkasan|Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan c4therapeutics.com|CCCC - Wutah bathi ing taun lumaku|Dinamika bathi saben saham sing diarepake ing taun ngarep C4 Therapeutics, Inc.

- rincian pendapatan lan dodolan emiten:

CCCC - Pendapatan lan volume dodolan|Volume dodolan sing dikarepake perusahaan C4 Therapeutics Inc|CCCC - Rasio rega marang pendapatan|Rega forward marang dodolan C4 Therapeutics Inc

Analisis komprehensif perusahaan:C4 Therapeutics - CCCC

The asset-light outsourcing model of C4 Therapeutics, Inc. (CCCC) defines the specific relationship between the stock price and the company's earnings. This ratio compares the asset's market value to net income, measuring the payback period for investments. The calculation is based on dividing the current quote by earnings per share, reflecting market expectations for drug development efficiency. Ignoring this context creates a risk of capital freeze.

Pesaing wigati

Kapitalisasi marang bathi Genmab GMAB|Pangali P/E EXEL|Nuvalent, Inc. (NUVL) - Rasio kapitalisasi marang bathi resik|Kymera Therapeutics, Inc. - Koefisien rega marang bathi|IDEAYA Biosciences, Inc. (IDYA) - Kapitalisasi marang bathi|ELVN: Koefisien rega marang bathi|Nilai perusahaan marang bathi resik ORIC (ORIC Pharma)|RLAY (Relay Therapeutics, Inc.) - Koefisien rega marang bathi|NRIX: Rasio rega pasar marang bathi resik|TYRA (Tyra Corp) - Pangali P/E|Pangali P/E verastem.com|Rasio rega marang bathi Monte Rosa Therapeutics, Inc. (GLUE)|CGEM (Cullinan Therapeutics, Inc.) - Nilai perusahaan marang bathi resik|Pangali P/E IMRX (Immuneering Corp)|Rasio kapitalisasi marang bathi resik Black Diamond Therapeutics Inc.|Repare Therapeutics, Inc. - Pangali P/E|Kapitalisasi marang bathi PMV Pharmaceuticals, Inc.|KPTI (karyopharm.com) - Koefisien rega marang bathi|PPCB: Rasio rega pasar marang bathi resik|BGMS (cyclacel.com) - Pangali P/E|Kapitalisasi marang bathi Aadi Bioscience AADI|Pangali P/E ALRN|Blueprint Medicines Corp - Pangali rega marang bathi|GlycoMimetics, Inc. - Koefisien rega marang bathi|Nilai perusahaan marang bathi resik SWTX